tiprankstipranks
Trending News
More News >
Bridgebio Pharma (BBIO)
:BBIO
US Market
Advertisement

BridgeBio Pharma (BBIO) Technical Analysis

Compare
1,371 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Bridgebio Pharma’s (BBIO) Moving Averages Convergence Divergence (MACD) indicator is 0.95, suggesting Bridgebio Pharma is a Buy.
Bridgebio Pharma’s (BBIO) 20-Day exponential moving average is 46.07, while Bridgebio Pharma’s (BBIO) share price is $47.75, making it a Sell.
Bridgebio Pharma’s (BBIO) 50-Day exponential moving average is 43.42, while Bridgebio Pharma’s (BBIO) share price is $47.75, making it a Buy.

BridgeBio Pharma (BBIO) Pivot Points

Aug 08, 2025, 03:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.89
40.49
42.65
44.25
46.41
48.01
50.17
Fibonacci
40.49
41.93
42.81
44.25
45.69
46.57
48.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BridgeBio Pharma (BBIO) Moving Averages

Aug 08, 2025, 03:04 PM
Period
Simple
Exponential
MA5
47.02Sell
46.51Sell
MA10
46.68Sell
46.58Sell
MA20
46.59Sell
46.07Sell
MA50
43.06Buy
43.42Buy
MA100
38.79Buy
40.03Buy
MA200
34.22Buy
35.32Buy
Bridgebio Pharma’s (BBIO) 10-Day exponential moving average is 46.58, while Bridgebio Pharma’s (BBIO) share price is $47.75, making it a Sell.
Bridgebio Pharma’s (BBIO) 100-Day exponential moving average is 40.03, while Bridgebio Pharma’s (BBIO) share price is $47.75, making it a Buy.
Bridgebio Pharma’s (BBIO) stock price is $47.75 and Bridgebio Pharma’s (BBIO) 50-day simple moving average is 43.06, creating a Buy signal.
Bridgebio Pharma’s (BBIO) stock price is $47.75 and Bridgebio Pharma’s (BBIO) 100-day simple moving average is 38.79, creating a Buy signal.
Bridgebio Pharma’s (BBIO) stock price is $47.75 and Bridgebio Pharma’s (BBIO) 200-day simple moving average is 34.22, creating a Buy signal.

BridgeBio Pharma (BBIO) Technical Indicators

Aug 08, 2025, 03:04 PM
Name
Value
Implied Action
RSI (14)
51.91
Neutral
STOCH (9,6)
57.89
Neutral
STOCHRSI (14)
57.89
Neutral
MACD (12,26)
0.95
Buy
ADX (14)
35.64
Neutral
Williams %R
-49.74
Buy
CCI (14)
-107.19
Buy
ATR (14)
1.95
-
Ultimate Oscillator
53.67
Neutral
ROC
-1.20
Sell
Bridgebio Pharma’s (BBIO) Relative Strength Index (RSI) is 51.91, creating a Neutral signal.
Bridgebio Pharma’s (BBIO) Trend Strength Indicator (ADX) is 35.64, creating a Neutral signal.
Bridgebio Pharma’s (BBIO) Commodity Channel Index (CCI) is -107.19, creating a Buy signal.
Bridgebio Pharma’s (BBIO) Price Rate of Change (ROC) is -1.20, creating a Sell signal.

FAQ

Is BBIO a Buy, Hold, or Sell?
Based on BBIO’s technical indicators, BBIO is a Hold.
    What is BBIO’s RSI (14)?
    BBIO’s RSI (14) is 51.91, which suggests BBIO is a Neutral.
      What is BBIO’s MACD?
      BBIO’s MACD is 0.95, which suggests BBIO is a Buy.
        What is BBIO’s 5-day moving average?
        BBIO’s 5-day moving average is 47.02, which suggests BBIO is a Sell.
          What is BBIO’s 20-day moving average?
          BBIO 20-day moving average is 46.59, which suggests BBIO is a Sell.
            What is BBIO’s 50-day moving average?
            BBIO’s 50-day moving average is 43.06, which suggests BBIO is a Buy.
              What is BBIO’s 200-day moving average?
              BBIO’s 200-day moving average is 34.22, which suggests BBIO is a Buy.
                What is BBIO’s Williams % R (14)?
                BBIO’s Williams % R (14) is -49.74, which suggests BBIO is a Buy.
                  What is BBIO’s CCI (14)?
                  BBIO’s CCI (14) is -107.19, which suggests BBIO is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis